| Literature DB >> 28851910 |
Tanaya Chatterjee1, Barun K Chatterjee2, Pinak Chakrabarti3,4.
Abstract
Emergence of multiple drug resistant strains of pathogenic bacteria calls for new initiatives to combat infectious diseases. Gold nanoparticles (AuNPs), because of their non-toxic nature and size/shape dependent optical properties, offer interesting possibility. Here we report the antibacterial efficacy of AuNPs of different size and shape (AuNS10, AuNS100 and AuNR10; the number indicating the diameter in nm; S stands for sphere and R for rod) against the classical (O395) and El Tor (N16961) biotypes of Vibrio cholerae, the etiological agent responsible for cholera. Growth kinetics was monitored by measuring optical density at different time intervals and fitted by non-linear regression of modified Buchanan model. Sigmoidal growth curve for VcO395 indicated the existence of single phenotype population and was affected by AuNR10 only, implying the importance of morphology of AuNP. Growth of VcN16961 was affected by all three AuNPs indicating the vulnerability of El Tor biotype. Interestingly, VcN16961 exhibited the occurrence of two phenotypic subpopulations - one with shorter (vulnerable Type 1) and the other with extended (tolerant Type 2) lag phase. Various assays were conducted to probe the impact of AuNPs on bacterial cells. Apart from AuNR10, antimicrobial efficacy of AuNS10 was better compared to AuNS100.Entities:
Mesh:
Substances:
Year: 2017 PMID: 28851910 PMCID: PMC5575114 DOI: 10.1038/s41598-017-09357-0
Source DB: PubMed Journal: Sci Rep ISSN: 2045-2322 Impact factor: 4.379
Figure 1(a) Growth kinetics and the variation of (b) growth rate and (c) delay time of VcO395 with different concentration of AuNR10.
Kinetic parameters obtained for Vc O395 using AuNR10.
| Conc. of AuNR10 (μM) | Maximum OD (AU) | Delay time (min) | Maximum growth rate (× 10−4 OD/min) |
|---|---|---|---|
| 0 | 0.42 ± 0.03 | 72 ± 7 | 9.1 ± 0.5 |
| 1 | 0.39 ± 0.04 | 80 ± 7 | 7.5 ± 0.9 |
| 2 | 0.31 ± 0.03 | 226 ± 17 | 6.6 ± 0.7 |
| 4 | 0.07 ± 0.003 | 410 ± 66 | 2.5 ± 0.3 |
Figure 2Growth kinetics of VcN16961 showing the existence of two subpopulations: Type 1 and Type 2 even in the absence of AuNPs.
Figure 3Growth kinetics, variation of growth rate and delay time of VcN16961 with different concentration of AuNPs. (a–c) For AuNS10; (d–f) for AuNS100; (g–i) for AuNR10.
Kinetic parameters obtained for Vc N16961 using different AuNPs.
| Type1 (vulnerable phenotype) | Type2 (tolerant phenotype) | ||||||
|---|---|---|---|---|---|---|---|
| Conc. of AuNPs (μM) | Maximum OD (AU) | Delay time (min) | Maximum growth rate (x 10−4 OD/min) | Maximum OD (AU) | Delay time (min) | Maximum growth rate (× 10−4 OD/min) | |
| Without AuNP | 0 | 0.22 ± 0.05 | 90 ± 16 | 38.5 ± 13.5 | 0.17 ± 0.03 | 433 ± 76 | 15.1 ± 13.5 |
| With AuNS10 | 10 | 0.16 ± 0.02 | 118 ± 9 | 24.7 ± 2.6 | 0.15 ± 0.02 | 441 ± 30 | 10.8 ± 2.6 |
| 20 | 0.12 ± 0.02 | 126 ± 6 | 20.6 ± 2.7 | 0.12 ± 0.01 | 432 ± 51 | 10.5 ± 3.1 | |
| 40 | 0.11 ± 0.01 | 128 ± 12 | 12.2 ± 0.9 | 0.06 ± 0.01 | 491 ± 25 | 5.1 ± 0.4 | |
| With AuNS100 | 10 | 0.15 ± 0.03 | 95 ± 8 | 24.2 ± 3.4 | 0.17 ± 0.04 | 505 ± 39 | 6.3 ± 3.4 |
| 20 | 0.11 ± 0.02 | 101 ± 5 | 22.4 ± 5.5 | 0.12 ± 0.03 | 456 ± 86 | 6.1 ± 2.2 | |
| 40 | 0.08 ± 0.01 | 95 ± 9 | 16.2 ± 4.1 | 0.13 ± 0.03 | 387 ± 28 | 3.5 ± 1.2 | |
| With AuNR10 | 2 | 0.09 ± 0.03 | 50 ± 5 | 13.0 ± 3.8 | 0.38 ± 0.10 | 450 ± 36 | 17.2 ± 6.3 |
| 4 | 0.03 | 182 ± 9 | 10.6 ± 6.4 | 0.44 | 425 ± 13 | 14.8 ± 3.0 | |
| 6 | — | — | — | 0.30 ± 0.03 | 468 ± 1 | 13.1 ± 1.3 | |
| 8 | — | — | — | 0.26 ± 0.06 0.18 ± 0.04 | 435 ± 23 | 16.5 ± 4.8 | |
| 10 | — | — | — | 0.1 | 475 ± 16 | 17.1 ± 10.0 | |
| 12 | — | — | — | 0.02 | 555 ± 13 | 16.7 ± 0.8 | |
| 14 | — | — | — | 1044 | 1.62 | ||
Figure 4Effect of AuNPs on (a) membrane fluidity (pI) and (b) protein leakage of classical and El tor biotypes of V. cholera.
Figure 5Confocal microscopic images of VcO395 cells, (a) control and (b) AuNR10 treated; and of VcN16961 cells, (c) control and (d) AuNR10 treated.